Matches in Wikidata for { <http://www.wikidata.org/entity/Q95497164> ?p ?o ?g. }
Showing items 1 to 29 of
29
with 100 items per page.
- Q95497164 description "article scientifique publié en 2019" @default.
- Q95497164 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95497164 description "wetenschappelijk artikel" @default.
- Q95497164 description "наукова стаття, опублікована в червні 2019" @default.
- Q95497164 name "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 name "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 type Item @default.
- Q95497164 label "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 label "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 prefLabel "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 prefLabel "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 P1433 Q95497164-4B9D3FE1-69FD-469A-8693-EF42D03C952C @default.
- Q95497164 P1476 Q95497164-40E5D79A-FC29-4C1F-8FAC-7B24B2D0127C @default.
- Q95497164 P2093 Q95497164-A78EAD32-18ED-4D97-A4FA-100B8BCF1AF4 @default.
- Q95497164 P31 Q95497164-16CE337E-A0C0-42EA-94BB-B4FCA77EA962 @default.
- Q95497164 P356 Q95497164-EEA3E746-41D6-4F6F-A449-72C6601B1A7B @default.
- Q95497164 P577 Q95497164-D797CCDA-A202-48A7-9434-F989FA348FDA @default.
- Q95497164 P698 Q95497164-350D878F-DC42-4324-847B-B666CABCD85D @default.
- Q95497164 P921 Q95497164-8FDFAA2D-3E5E-4100-8FC4-BEAAB7B6E824 @default.
- Q95497164 P356 J.JAAD.2019.05.081 @default.
- Q95497164 P698 31163230 @default.
- Q95497164 P1433 Q15757046 @default.
- Q95497164 P1476 "Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis" @default.
- Q95497164 P2093 "Mark G Lebwohl" @default.
- Q95497164 P31 Q13442814 @default.
- Q95497164 P356 "10.1016/J.JAAD.2019.05.081" @default.
- Q95497164 P577 "2019-06-01T00:00:00Z" @default.
- Q95497164 P698 "31163230" @default.
- Q95497164 P921 Q10355321 @default.